Lung cancer and interstitial lung disease

J. Cadranel (Paris Cedex 20, France)

Source: International Congress 2018 – State of the art session: Thoracic oncology
Session: State of the art session: Thoracic oncology
Session type: Symposium
Number: 1898

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Cadranel (Paris Cedex 20, France). Lung cancer and interstitial lung disease. International Congress 2018 – State of the art session: Thoracic oncology

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung cancer in ILD
Source: ERS Course 2016
Year: 2016




Interstitial lung diseases and lung cancer
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer
Source: International Congress 2016 – Orphan diseases I
Year: 2016

Lung biopsy in the diagnostics of interstitial lung disease
Source: Eur Respir J 2007; 30: Suppl. 51, 561s
Year: 2007

Interstitial lung disease
Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Year: 2019


Interstitial lung disease
Source: ERS Course 2018 - Thoracic imaging
Year: 2018


Interstitial lung disease
Source: Eur Respir Monogr 2019; 83: 173-187
Year: 2019


Interstitial lung disease
Source: School Course 2012 - Thoracic Imaging
Year: 2012

Interstitial lung disease
Source: Eur Respir Rev 2014; 23: 40-54
Year: 2014



Interstitial lung disease
Source: Eur Respir Monogr 2014; 66: 218-231
Year: 2014


Interstitial lung disease
Source: International Congress 2015 – Interstitial lung disease, pulmonary hypertension, pulmonary embolism and sleep apnoea
Year: 2015



Interstitial lung disease
Source: ERS Course 2015
Year: 2015



Biomarkers for interstitial lung disease
Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease
Year: 2016



Lung resistance-related protein in lung cancer and lung lesions in Hodgkin disease
Source: Eur Respir J 2006; 28: Suppl. 50, 86s
Year: 2006

Connective tissue disease-related interstitial lung disease and lung cancer
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018